Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Lader

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Depression and Anxiety|January 12, 2005
Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensionsDan J Stein, Siegfried Kasper, Elisabeth Wreford Andersen, et al.
Drug Safety|January 15, 2005
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden deathKarine Titier, Pierre-Olivier Girodet, Hélène Verdoux, et al.
Human Psychopharmacology|October 31, 2002
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study daggerJean Pierre Lepine, Carlo Altamura, Marc Ansseau, et al.
International Clinical Psychopharmacology|October 6, 2007
Which antidepressants have demonstrated superior efficacy? A review of the evidenceStuart A Montgomery, David S Baldwin, Pierre Blier, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 25, 2008
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revisionBorwin Bandelow, Joseph Zohar, Eric Hollander, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Depression and Anxiety|January 12, 2005
Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensionsDan J Stein, Siegfried Kasper, Elisabeth Wreford Andersen, et al.
Drug Safety|January 15, 2005
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden deathKarine Titier, Pierre-Olivier Girodet, Hélène Verdoux, et al.
Human Psychopharmacology|October 31, 2002
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study daggerJean Pierre Lepine, Carlo Altamura, Marc Ansseau, et al.
International Clinical Psychopharmacology|October 6, 2007
Which antidepressants have demonstrated superior efficacy? A review of the evidenceStuart A Montgomery, David S Baldwin, Pierre Blier, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 25, 2008
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revisionBorwin Bandelow, Joseph Zohar, Eric Hollander, et al.
Pageof 3